纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的生物相容性与体内降解研究

对制备的纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的生物相容性及体内降解情况进行研究,为临床提供实验依据.参照GB/T16886医疗器械生物学评价标准和要求,对纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥进行急性细胞毒性试验、溶血试验、热源试验、急性全身毒性试验及体内植入试验等系列体内外生物学试验研究,以进行有效的生物相容性和安全性评价.纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的溶血率小于国家规定的5％,在体外不引起溶血反应;浸提液注入动物体内后无死亡,活动进食正常;无细胞毒性反应;热原试验动物体温升高均在0.7℃以下,3只兔体温升高值的总数＜1.5℃,无致热作用;材料植入体内初期有轻度炎症反应,随植入时间延长逐渐减轻,材料也逐渐降解吸收.纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥具有良好的生物相容性和降解性能,具有临床开发应用前景.     

新型抗菌乳胶制备及其针对泌尿系统常见致病菌体外抑菌研究

目的 采用一种绿色、低毒性的工艺制备羧甲基壳聚糖复合纳米银(CMCS-AgNPs),并与天然乳胶共混得到针对泌尿系统常见致病菌的抗菌型乳胶,为开发新型抗菌型导尿管或输尿管支架管提供一种选择材料.方法 以7g/L硝酸银溶液为原料,1 g/L羧甲基壳聚糖溶液为还原稳定剂,二者按体积比5:95充分混合,在水热、碱性条件下反应...     

纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的生物相容性与体内降解研究

对制备的纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的生物相容性及体内降解情况进行研究,为临床提供实验依据。参照GB/T16886医疗器械生物学评价标准和要求,对纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥进行急性细胞毒性试验、溶血试验、热源试验、急性全身毒性试验及体内植入试验等系列体内外生物学试验研究,以进行有效的生物相容性和安全性评价。纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的溶血率小于国家规定的5%,在体外不引起溶血反应;浸提液注入动物体内后无死亡,活动进食正常;无细胞毒性反应;热原试验动物体温升高均在0.7℃以下,3只兔体温升高值的总数〈1.5℃,无致热作用;材料植入体内初期有轻度炎症反应,随植入时间延长逐渐减轻,材料也逐渐降解吸收。纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥具有良好的生物相容性和降解性能,具有临床开发应用前景。     

基于壳聚糖的纳米材料在骨组织工程与再生医学中的研究进展

壳聚糖是目前发现的唯一与细胞外基质糖胺聚糖的化学结构相似的天然阳离子多聚糖,具有极为优良的生物相容性、生物可降解性和生物学活性.近年来,基于壳聚糖的纳米材料在组织工程中的研究较为广泛.对壳聚糖的纳米材料、壳聚糖复合纳米材料、壳聚糖纳米纤维和壳聚糖纳米粒子等在骨组织工程与再生医学中的研究进展进行回顾和阐述.近年来的研究显示,壳聚糖复合纳米材料生物支架、壳聚糖纳米纤维支架及包载具有骨诱导性的生物活性因子,以及外源基因的壳聚糖纳米粒子及纳米纤维,在骨组织工程与再生医学中具有良好的应用前景.     

聚乳酸载药纳米微粒的表面修饰及体外评价

本研究的目的是用O 羧甲基壳聚糖作乳化剂和表面修饰剂 ,采用超声乳化法制备聚乳酸载药纳米微粒 ,并对聚乳酸载药纳米微粒进行表面修饰 ,然后分别对载药纳米微粒的表面形貌、粒径分布、微粒结构、表面元素、体外释放和肿瘤细胞抑制率等微粒性能进行考察与评价。实验证明 ,O 羧甲基壳聚糖可用于制备纳米药物载体系统 ,对聚乳酸载药纳米微粒的制备起到很好的乳化性能和表面修饰作用。采用复乳法制备包载 5 Fu的PLA/O CMC纳米微粒的平均粒径在 5 0nm ,在PBS缓冲溶液中释放时间可达 12d。在对胃癌、乳腺癌和大肠癌三种肿瘤细胞的抑制率测定实验中 ,PLA/O CMC纳米微粒的肿瘤细胞抑制率分别可以达到 72 .8%、77.3%和 75 .6 % ,接近或等同于游离 5 Fu药物的抑制率。在作用时间上 ,PLA/O CMC载药纳米微粒也显示出良好的缓释效应。     

羧甲基壳聚糖用作防止术后粘连的研究

本研究合成制备了N-羧甲基壳聚糖（N-CMC）、O-羧甲基壳聚糖（O-CMC）和N,O-羧甲基壳聚糖（N,O-CMC）;研究了它们的凝血性、体外酶解、抑菌性、对细胞生长的影响、对胶原合成的作用等生物特性;评价了它们的动物体内防粘连效果.研究结果表明,与N-CMC和N,O-CMC相比,O-CMC具有良好的凝血性,良好的生物降解性,轻微的抑菌活性,适度的抑制成纤维细胞增殖作用,轻微的抑制表皮细胞增殖作用,能抑制成纤维细胞胶原合成的能力,显示较好的防止术后粘连的效果,有希望成为新一代术后防止粘连材料.     

纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥的性能

背景：目前普遍使用的黏合剂对粉碎骨折块进行黏合复位或多或少都存在一些缺陷。 目的：研制具有黏接骨骼作用的生物活性骨水泥。 方法：应用共沉淀法制备纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合材料作为骨水泥的固相粉体,将柠檬酸衍生物配制成溶液作为液相。通过优化实验,从骨水泥的固化时间、抗压强度、抗拉强度、抗稀散性等方面确定最佳配比。 结果与结论：纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠质量比为65/35,其中羧甲基壳聚糖和海藻酸钠质量比为4∶1时复合成粉体,并按固液比为1.0∶0.5(g∶mL)调拌后形成的骨水泥呈膏状,塑形性和抗稀散性能良好,固化时间12~18 min,抗压强度为(4.5±2.1) MPa。体外黏接猪股骨头抗拉强度在不同室温下无显著性差异无显著性意义(P > 0.05),固化后2 h的抗拉强度达到24 h的94%。骨水泥为多孔状结构,孔径为100~300 μm,纳米羟基磷灰石分布较均匀。提示制备的纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥具有良好的生物活性、适当的力学强度以及较好的黏合强度。     

镧系铕配位羧甲基壳聚糖止血海绵的研究

本研究以羧甲基壳聚糖与镧系金属铕水合物进行配位,经发泡和冷冻干燥工艺制备得到镧系铕配位羧甲基壳聚糖止血海绵。通过扫描电镜(SEM)分析、吸液倍率测试、荧光光谱分析、大鼠背部止血实验和抑菌试验分别对该止血海绵的物理、化学及生物性能进行研究。该止血海绵呈多孔层状,吸液率达30~33倍,具有红色特征荧光性能。用于大鼠背部出血时,能迅速止血,粘附创面。对大肠杆菌、金黄色葡萄球菌、枯草杆菌有抑菌作用。该止血海绵可用于创面止血抑菌、特殊标记感染区和特征光学显示,在外科手术和家庭护理等方面具有很好的前景。     

Apoptin基因/壳聚糖缓释微球的制备及其对A375细胞的凋亡诱导作用

目的:以羧甲基壳聚糖为基质材料,制备apoptin基因缓释微球.方法:采用复凝聚法制备apoptin/壳聚糖微球,分别用光镜观察微球形态、内切酶研究其稳定性、DNA电泳阻滞分析apoptin/壳聚糖最佳比例、PCR测定apoptin基因作为复制摸板能力、用MTT法检测其抗肿瘤活性.结果:壳聚糖与apoptin基因可形成稳定的微球,其直径在200～300 nm之间,成球性较好、apoptin/壳聚糖微球P/N最佳质量比为5.5:1、微球能够有效防止DNA酶的降解作用、apoptin/微球载体中的基因仍具有DNA复制模板功能,并能有效地转染A375细胞,诱导A375细胞发生凋亡,从而抑制瘤细胞生长.结论:apoptin基因与羧甲基壳聚糖可形成稳定的缓释微球,并能有效地转染肿瘤细胞,诱导肿瘤细胞发生凋亡.     

纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥与骨髓基质细胞的生物相容性*☆

背景：在前期的试验中,通过共沉淀法合成了纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合粉体,并与柠檬酸衍生物溶液调和制备出可生物降解、适当力学性能以及较好黏合强度的骨水泥。 目的：验证纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥材料对体外兔骨髓基质细胞黏附及增殖的影响,了解材料的生物相容性。 方法：应用共沉淀法制备纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合材料作为骨水泥的固相粉体,将柠檬酸衍生物配制成溶液作为液相调和制备黏合性骨水泥。培养兔骨髓基质细胞,传代扩增后接种到材料上,体外继续培养;以细胞加入无材料的培养皿培养为对照。 结果与结论：体外培养的兔骨髓基质细胞2 d后呈梭形成纤维细胞样,生长良好。有材料实验组细胞数显著多于对照组(P < 0.01)。扫描电镜下骨水泥材料具有良好的多孔网状结构,兔骨髓基质细胞伸出多个伪足样突起,紧密贴附在材料表面。两组细胞均保持持续增殖,2,4,6,和8 d实验组增殖均显著快于对照组(P < 0.01)。提示纳米羟基磷灰石/羧甲基壳聚糖-海藻酸钠复合骨水泥材料具有良好的生物相容性。      

Ag nanoparticles decorated electrospinning carbon nanotubes/polyamide nanofibers

Abstract

Antibacterial composite nanofibers have recently been widely applied in biomedical fields. The purpose of this study is to combine Polyamide66 (PA) with carbon nanotubes (CNTs) and Ag nanoparticles through electrospinning and the aqueous reduction method to synthesis Ag@CNT/PA composite nanofibers with excellent conductivity, antibacterial property and cytocompatibility. The morphology and structure of Ag@CNT/PA composite nanofibers were analyzed by a series of characterizations. Conductivity of Ag@CNT/PA composite nanofibers in wet state was measured using a four-probe resistance tester. The antibacterial activity of Ag@CNT/PA composite nanofibers was tested by inhibition zone method, and the MG-63 cells were used to detect the cytotoxicological effects of the composite nanofibers. The results show that the Ag nanoparticles (50–100?nm) are distributed uniformly on the surface of nanofibers. Conductivity of Ag@CNT/PA composite nanofibers reaches (9.918?±?0.043)?×?10^?4?S?mm^?1, significantly higher than that of PA nanofibers ((1.486?±?0.017)?×?10^?4?S?mm^?1). The Ag@CNT/PA composite fibers present good antibacterial activity against Escherichia coli and Staphylococcus aureus. Cell culture results show that the cell proliferation of Ag@CNT/PA composite nanofiber group seems no significant difference with PA nanofiber group (p?>?0.05) at day 7. The Ag@CNT/PA composite nanofibers have no significant negative effects on MG-63 cells.     

Cell outer membrane mimetic chitosan nanoparticles: preparation,characterization and cytotoxicity

A negatively charged copolymer poly (MPC-co-AMPS) of 2-methacryloyloxyethyl phosphorylcholine (MPC) and 2-acrylamide-2-methyl propane sulfonic acid (AMPS) was designed and synthesized. Chitosan nanoparticles with cell outer membrane mimetic structure were prepared by electrostatic interaction between the sulfonic acid groups of poly (MPC-co-AMPS) and the protonated amino groups of chitosan. Effects of factors on influencing the particle size, distribution, and stability were investigated. The experimental results showed that cell membrane mimetic chitosan nanoparticles with controllable and homogeneous size ranged from 100 to 300 nm were prepared at the concentration of 0.1–2.0 mg/mL and the charge ratio of 0.5–1.1. Chitosan nanoparticles prepared can exist stably for more than 45 days when placed at 4° C and pH < 7.5. The cytotoxicity of the chitosan nanoparticles reduced significantly after surface modification with cell membrane mimetic structure, meeting the basic requirements of biomedical materials. The results suggest cell membrane mimetic chitosan nanoparticles prepared with polyanion and polycation obtain good biological compatibility and immune stealth ability, which has important academic significance and great application prospects.     

创面复合液体敷料在皮肤创伤中的治疗研究

基于羧甲基壳聚糖的高生物相容性及聚乙烯醇缩丁醛的快速成膜,构建了一种创面复合液体敷料,并对其应用效果进行评价。首先应用羧甲基壳聚糖 (CMC)、聚乙烯醇缩丁醛 (PVB)和乙醇溶液,按照一定的比例,制备创面复合液体敷料。对其防水、透气、阻菌、细胞毒性进行性能研究及安全性评价。然后选择健康成年Sprague-Dawley(SD)大鼠40只,雌雄各半,构建大鼠创面模型,并将含有不同浓度的羧甲基壳聚糖(1.0、10.0、30.0 mg/mL)应用在其创面上,通过日常观察、HE染色等,研究创面复合液体敷料在皮肤创伤中的治疗效果。结果显示创面复合液体敷料上层膜液在1.8～2.3 mm 之间具有很好的防水透气性、阻菌性及生物兼容性。运用在动物模型上可以看到,第7 d含有10.0、30.0 mg/mL CMC组的大鼠创面愈合率分别为65.42%、67.38%,明显高于对照组且存在显著性差异(P< 0.01),14 d后含有10.0、30.0 mg/mL CMC组的大鼠创面愈合率已达到100%。HE 染色的第七天含有10.0、30.0 mg/mL CMC的创面复合液体敷料组中观察到有复层扁平的表皮和真皮的胶原纤维,第12 d组织开始出现内陷结构,含有厚实、粗糙胶原纤维的正常真皮与较薄的胶原纤维水平连接,表皮的复层鳞状上皮远远大于对照组中的三到四层。而且创面连接真皮结缔组织,它的表皮构成非常接近于正常皮肤组织。构建的创面复合液体敷料(10.0 mg/mL CMC)具备良好的防水、透气、阻菌性以及生物兼容性,随着羧甲基壳聚糖浓度的升高,治疗急性创面的效果越好,创面复合液体敷料能够对创面起到早期保护和促进愈合的效果。.     

人牙周膜细胞在羧甲基壳聚糖和血小板衍生生长因子BB环境中的增殖

背景：羧甲基壳聚糖或血小板衍生生长因子均可促进对体外培养人牙周膜细胞的增殖。 目的：观察羧甲基壳聚糖和血小板衍生生长因子BB联合应用对体外培养人牙周膜细胞增殖和分化能力的影响。 方法：取生长良好的第4或5代人牙周膜细胞,分组培养：对照组(仅含体积分数2%FBS的DMEM培养液)、10 μg/L 血小板衍生生长因子BB组、100 mg/L羧甲基壳聚糖+10 μg/L 血小板衍生生长因子BB组、800 mg/L 羧甲基壳聚糖+10 μg/L 血小板衍生生长因子BB组、100 mg/L羧甲基壳聚糖组、800 mg/L羧甲基壳聚糖组。 结果与结论：①MTT检测：与对照组比较,其余各组均能促进人牙周膜细胞增殖,且100 mg/L羧甲基壳聚糖+ 10 μg/L血小板衍生生长因子BB、800 mg/L 羧甲基壳聚糖+ 10 μg/L血小板衍生生长因子BB组细胞增殖高于其他组(P < 0.05),100 mg/L 羧甲基壳聚糖+10 μg/L血小板生性生长因子BB促增殖作用最显著(P < 0.05)。②细胞周期检测：与MTT检测结果相符。③碱性磷酸酶活性：与对照组比较,除10 μg/L 血小板衍生生长因子BB组降低外,其余组均增强(P < 0.05)。表明羧甲基壳聚糖和血小板衍生生长因子BB联合应用可促进人牙周膜细胞增殖和骨向分化。     

载基因壳聚糖纳米粒的制作优化和表征

目的 改良和优化载基因壳聚糖纳米微粒制作方法.方法 制备具有水溶性的磷酸化壳聚糖(pCS),再将pCS与甲胎蛋白基因的探针按不同比例浓度混合制作纳米粒.测量纳米粒径及电位变化,以及改变溶液pH值对包封率的影响.应用拉曼光谱分析纳米粒荧光强度变化.结果 改良制作纳米粒的方法更简单,粒径(144.6±6.8)nm与常规方法制作纳米粒粒径(153.4±18.9)mn差异无统计学意义(P＞0.05).通过优化条件,pCS与基因探针摩尔浓度比例为2∶1时最理想,改良法制作纳米粒径为(102.6±12.0)nm,zeda电位为(1.45±1.75)mV,包封率为(87.6±3.5)%.纳米材料的表征分析显示pCS与探针可结合形成纳米颗粒,并且包封基因探针.结论 优化微量法制作载基因壳聚糖纳米粒的方法可行和简单,pCS可包封基因探针.     

Surface antimicrobial activity and biocompatibility of incorporated polyethylenimine nanoparticles

The antimicrobial effect and biocompatibility of insoluble cross-linked quaternary ammonium polyethylenimine (PEI) nanoparticles incorporated at 1 or 2%w/w in a resin composite were assayed. The antimicrobial effect against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Pseudomonas aeruginosa and Escherichia coli was tested using the direct contact test (DCT), agar diffusion test (ADT) and scanning electron microscopy (SEM). Biocompatibility was tested by assessing macrophage viability, and TNFalpha secretion. Samples incorporating 2%w/w nanoparticles inhibited the growth of all bacterial strains tested. Reducing the amount of the added nanoparticles to 1%w/w resulted in complete inhibition of S. aureus and E. faecalis, and decreased growth of S. epidermidis, P. aeruginosa and E. coli (p<0.0001). The DCT results were confirmed by SEM. However, ADT showed no inhibition halo in all test bacteria, indicating the antimicrobial nanoparticles are not diffusing into the agar milieu. Biocompatibility tests revealed macrophage viability, and TNFalpha secretion was not altered by the presence of the nanoparticles in the resin. Incorporation of PEI nanoparticles in a resin composite had a long lasing antimicrobial effect against a wide range of bacteria with no measured effect on biocompatibility.     

Biological actions of silver nanoparticles embedded in titanium controlled by micro-galvanic effects

Titanium embedded with silver nanoparticles (Ag NPs) using a single step silver plasma immersion ion implantation (Ag-PIII) demonstrate micro-galvanic effects that give rise to both controlled antibacterial activity and excellent compatibility with osteoblasts. Scanning electron microscopy (SEM) shows that nanoparticles with average sizes of about 5 nm and 8 nm are formed homogeneously on the titanium surface after undergoing Ag-PIII for 0.5 h and 1 h, respectively. Transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS) indicate that those nanoparticles are metallic silver produced on and underneath the titanium surface via a local nucleation process from the solid solution of α-Ti(Ag). The Ag-PIII samples inhibit the growth of both Staphylococcus aureus and Escherichia coli while enhancing proliferation of the osteoblast-like cell line MG63. Electrochemical polarization and Zeta potential measurements demonstrate that the low surface toxicity and good cytocompatibility are related to the micro-galvanic effect between the Ag NPs and titanium matrix. Our results show that the physico-chemical properties of the Ag NPs are important in the control of the cytotoxicity and this study opens a new window for the design of nanostructured surfaces on which the biological actions of the Ag NPs can be accurately tailored.     

Innovative biosynthesis of silver nanoparticles using yeast glucan nanopolymer and their potentiality as antibacterial composite

Nanometals (NM) frequently possess potent antimicrobial potentials to combat various pathogens, but their elevated biotoxicity limits their direct applications. The biosynthesis of NM and their capping/conjugation with natural biopolymers can effectually enhance NM stability and diminish such toxicity. Yeast β-glucan (βG), from Saccharomyces cerevisiae, was extracted and transformed to nanoparticles (NPs) using alkali/acid facile protocol. The βG NPs were innovatively employed for direct biosynthesis of silver nanoparticles (Ag NPs) without extra chemical processes. The physicochemical assessments (Fourier-transform infrared, X-ray diffraction, and transmission electron microscopy) validated NPs formation, interaction, and interior capping of Ag NPs in βG NPs. The synthesized βG NPs, Ag NPs, and βG–Ag NPs composite were negatively charged and had minute particle sizes with mean diameters of 58.65, 6.72, and 63.88 nm, respectively. The NPs (plain Ag NPs and composited βG–Ag NPs) exhibited potent comparable bactericidal actions, opposing Gram⁺ (Staphylococcus aureus) and Gram^‒ (Escherichia coli, Salmonella Typhimurium, and Pseudomonas aeruginosa). Scanning micrographs, of treated S. aureus and S. Typhimurium with βG–Ag NPs, elucidated the powerful bactericidal actions of nanocomposite for destructing pathogens' cells. The inventive Ag NPs biosynthesis with βG NPs and the combined βG–Ag NPs nanocomposites could be impressively recommended as powerful antibacterial candidates with minor potential toxicity.     

Synthesis,characterization, and biological activity of cross-linked chitosan biguanidine loaded with silver nanoparticles

Chitosan biguanidine hydrochloride (ChG) and glutaraldehyde cross-linked chitosan biguanidine (CChG) were synthesized and characterized by Fourier transform infrared spectroscopy, ¹H NMR and ¹³C NMR, X-ray diffraction, scanning electron microscopy (SEM) and thermal analyses (TGA and DTA). The results showed that ChG and CChG had a more amorphous structure than that of chitosan, and their thermal stability were slightly lower than that of chitosan. Colloidal silver nanoparticles (AgNPs) were prepared using borohydride reduction method and then investigated as fillers in partially cross-linked chitosan biguanidine. The obtained nanoparticles were uniform and spherical with average size of 9.6 ± 0.5 nm. The prepared CChG/AgNPs composites were characterized for their morphology, thermal properties, cytotoxicity and antimicrobial activity. The SEM images showed that the AgNPs are well imbedded in the CChG matrix. The thermal stability of CChG was improved with incorporation of AgNPs. The CChG and CChG/AgNPs showed less cytotoxicity to breast cancer cells (MCF-7). Compared with chitosan and CChG, the ChG and CChG/AgNPs showed better antimicrobial activity against Streptococcus pneumoniae and Bacillus subtilis as Gram-positive bacteria, Escherichia coli as Gram-negative bacteria and Aspergillus fumigatus, Geotricum candidum and Syncephalastrum recemosum as fungi.     

偏磷酸钙纳米粒子的细胞相容性

背景：偏磷酸钙具有优异的细胞相容性能和降解性能及细胞亲和性,人骨髓间充质干细胞可以在多孔偏磷酸钙孔洞内生长和增殖,但有关偏磷酸钙纳米粒子的研究较少。 目的：制备纳米级偏磷酸钙微粒,通过流式细胞术快速检测不同浓度纳米级偏磷酸钙微粒对人骨髓间充质干细胞凋亡的影响。 方法：采用湿法球磨法制备偏磷酸钙纳米粒子,通过扫描电镜和透射电镜观察纳米粒子的形貌,通过X射线衍射分析确定纳米粒子的晶体结构。将偏磷酸钙纳米粒子混入CYAGON OricellTM 基础培养基,使得偏磷酸钙纳米粒子的质量浓度分别为10,1,0.1 mg/L,将其与人骨髓间充质干细胞共培养7 d,通过流式细胞术分析偏磷酸钙纳米粒子质量浓度与细胞凋亡的关系。 结果与结论：采用湿法球磨法成功制备了偏磷酸钙纳米粒子,直径为10-30 nm,粒径分布较均匀,分散性较好,但晶体形状不规则;X射线衍射分析晶相检测其主晶相为β-Ca(PO3)2晶体。10 mg/L质量浓度组细胞G0/G1和G2/M比例高于1,0.1 mg/L质量浓度组(P < 0.01);10 mg/L质量浓度组细胞早期、中晚期、总细胞凋亡率高于1,0.1 mg/L质量浓度组(P < 0.01);说明偏磷酸钙纳米粒子对人骨髓间充质干细胞的增殖有影响,当其质量浓度从1 mg/L增加至10 mg/L后,细胞凋亡率显著增加。